Education
About Us
Working with TipRanks
Follow Us
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
:SPLY
SPLY Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.12
Previous CloseN/A
Volume19.00K
Average Volume (3M)79.73K
Market Cap
C$11.83M
Enterprise ValueC$915.89K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)0.00
Price to Earnings (P/E)―
Beta-0.39
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding169,025,220
10 Day Avg. Volume51,449
30 Day Avg. Volume79,727
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-6.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Origin Therapeutics Holdings, Inc. News
PremiumCompany Announcements
Safe Supply Streaming Co. Ltd. Strengthens Leadership and Financial Strategy
PremiumCompany Announcements
Safe Supply Completes Acquisition of Safety Strips Tech Corp.
PremiumCompany Announcements
Safe Supply Donates Fentanyl Test Kits to Media for Harm Reduction
PremiumCompany Announcements
Safe Supply Leads Fight Against Fentanyl Crisis with Strategic Acquisitions
PremiumCompany Announcements
Safe Supply Announces Board Change Amid Strategic FocusPremiumCompany Announcements
Safe Supply Teams with Greenlane for Toxi Shield Distribution
PremiumCompany Announcements
Safe Supply Streaming Co. Appoints New CFO---
Options Prices
Currently, No data available
---
Ownership Overview
8.28% Insiders
―
Mutual Funds
― Other Institutional Investors
91.72% Public Companies and
Individual Investors
SPLY FAQ
What was Origin Therapeutics Holdings, Inc.’s price range in the past 12 months?
Origin Therapeutics Holdings, Inc. lowest stock price was C$0.01 and its highest was C$0.12 in the past 12 months.
What is Origin Therapeutics Holdings, Inc.’s market cap?
Origin Therapeutics Holdings, Inc.’s market cap is C$11.83M.
When is Origin Therapeutics Holdings, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Origin Therapeutics Holdings, Inc.’s earnings last quarter?
Origin Therapeutics Holdings, Inc. released its earnings results on Aug 27, 2024. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
Is Origin Therapeutics Holdings, Inc. overvalued?
According to Wall Street analysts Origin Therapeutics Holdings, Inc.’s price is currently Overvalued.
Does Origin Therapeutics Holdings, Inc. pay dividends?
Origin Therapeutics Holdings, Inc. does not currently pay dividends.
What is Origin Therapeutics Holdings, Inc.’s EPS estimate?
Origin Therapeutics Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Origin Therapeutics Holdings, Inc. have?
Origin Therapeutics Holdings, Inc. has 169,025,220 shares outstanding.
What happened to Origin Therapeutics Holdings, Inc.’s price movement after its last earnings report?
Origin Therapeutics Holdings, Inc. reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Origin Therapeutics Holdings, Inc.?
Currently, no hedge funds are holding shares in TSE:SPLY
---
Company Description
Origin Therapeutics Holdings, Inc.
Origin Therapeutics Holdings Inc is an investment company primarily focusing on investments in the psychedelic industry. The Company plans to invest in opportunities involving, where legally permitted, the research, design, development, testing, production, distribution and sale of psychedelics and services related thereto.
---
Technical Analysis
---